SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021786
Filing Date
2021-11-04
Accepted
2021-11-04 16:22:02
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20210930.htm   iXBRL 10-Q 1663997
2 EX-31.1 ngm-20210930x10qex311.htm EX-31.1 11115
3 EX-31.2 ngm-20210930x10qex312.htm EX-31.2 11104
4 EX-32.1 ngm-20210930x10qex321.htm EX-32.1 7564
  Complete submission text file 0001628280-21-021786.txt   6636099

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20210930.xsd EX-101.SCH 44018
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20210930_cal.xml EX-101.CAL 49302
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20210930_def.xml EX-101.DEF 164208
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20210930_lab.xml EX-101.LAB 521124
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20210930_pre.xml EX-101.PRE 318685
10 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20210930_htm.xml XML 1122645
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 211380357
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences